» Articles » PMID: 36235700

Structural Characterization of a Polysaccharide and Its Neuroprotection Related to the Inhibition of Oxidative Stress

Overview
Journal Nutrients
Date 2022 Oct 14
PMID 36235700
Authors
Affiliations
Soon will be listed here.
Abstract

A novel polysaccharide PSP2-1 was isolated and purified from . The structural characterization data displayed that the molecular weight of PSP2-1 was 44.9 kDa, and PSP2-1 consisted of fucose, galactose, glucose, and mannose. The methylation results showed that the glycosidic bonds of PSP2-1 included T-Fuc, 1,6-Gal, T-Glc, 1,6-Glc, 1,3,6-Glc, 1,3-Man, 1,2,6-Man, and T-Man. Neuroprotective studies indicated that PSP2-1 significantly improved the cell viability of the HO-induced oxidatively damaged neuronal cell HT22, reduced the release of LDH, inhibited apoptosis and release of cytochrome c, and alleviated the decline of mitochondrial membrane potential and ROS accumulation. Furthermore, PSP2-1 decreased the phosphorylation levels of cleaved PARP and cleaved caspase-3, and increased the ratio of bcl-2/bax. Additionally, PSP2-1 could inhibit the phosphorylation of MAPK family members including JNK, p38, and Erk. Finally, animal experiments showed that PSP2-1 could improve the oxidative stress injury and the learning and memory ability of mice with aging induced by D-galactose. Our results confirmed that PSP2-1 significantly ameliorated the oxidative stress injury, inhibited the apoptosis in HO-induced neuronal cells via MAPK pathway, and also improved cognition in mice with aging induced by D-galactose. Our research gives the foundation for the functional food application of polysaccharides in the future.

Citing Articles

Mechanisms of action of fungal polysaccharides and their therapeutic effect.

Zaitseva O, Sergushkina M, Polezhaeva T, Solomina O, Khudyakov A Eur J Clin Nutr. 2024; .

PMID: 39433857 DOI: 10.1038/s41430-024-01527-4.


Optimization of the Deproteinization Process via Response Surface Methodology, Preliminary Characterization, and the Determination of the Antioxidant Activities of Polysaccharides from L. SuoSuo.

Ma X, Wu Y, Gao P, Zheng Q, Lu Y, Yuan F Molecules. 2024; 29(19).

PMID: 39407662 PMC: 11478254. DOI: 10.3390/molecules29194734.


Alleviating effect of chlorogenic acid on oxidative damage caused by hydrogen peroxide in bovine intestinal epithelial cells.

Lu J, An Y, Wang X, Zhang C, Guo S, Ma Y J Vet Med Sci. 2024; 86(9):1016-1026.

PMID: 39069486 PMC: 11422687. DOI: 10.1292/jvms.24-0148.


Antitumor Activity of Carboxymethyl Pachymaran with Different Molecular Weights Based on Immunomodulatory and Gut Microbiota.

Zhao Y, Feng X, Zhang L, Huang W, Liu Y Nutrients. 2023; 15(21).

PMID: 37960180 PMC: 10648391. DOI: 10.3390/nu15214527.


D-galactose causes sinoatrial node dysfunction: from phenotype to mechanism.

Zhang H, Chen C, Liu Y, Chen W, Qi J, Xu Y Aging (Albany NY). 2023; 15(21):12551-12569.

PMID: 37950730 PMC: 10683603. DOI: 10.18632/aging.205196.


References
1.
Zhang C, Li Z, Zhang C, Li M, Lee Y, Zhang G . Extract Methods, Molecular Characteristics, and Bioactivities of Polysaccharide from Alfalfa ( L.). Nutrients. 2019; 11(5). PMC: 6567097. DOI: 10.3390/nu11051181. View

2.
Carbonero E, Ruthes A, Freitas C, Utrilla P, Galvez J, Silva E . Chemical and biological properties of a highly branched β-glucan from edible mushroom Pleurotus sajor-caju. Carbohydr Polym. 2012; 90(2):814-9. DOI: 10.1016/j.carbpol.2012.06.005. View

3.
Carbonero E, Gracher A, Rosa M, Torri G, Sassaki G, Gorin P . Unusual partially 3-O-methylated alpha-galactan from mushrooms of the genus Pleurotus. Phytochemistry. 2007; 69(1):252-7. DOI: 10.1016/j.phytochem.2007.06.018. View

4.
Chen S, Zhou H, Zhang G, Meng J, Deng K, Zhou W . Anthocyanins from Lycium ruthenicum Murr. Ameliorated d-Galactose-Induced Memory Impairment, Oxidative Stress, and Neuroinflammation in Adult Rats. J Agric Food Chem. 2019; 67(11):3140-3149. DOI: 10.1021/acs.jafc.8b06402. View

5.
Jiang T, Sun Q, Chen S . Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease. Prog Neurobiol. 2016; 147:1-19. DOI: 10.1016/j.pneurobio.2016.07.005. View